Effect of hypertherrnia on cisplatin pharrnacokinetics in normal dogs

References

• Alberts D. S., Peng Y. M., Chen G., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–460
   PubMed Web of Science ®Google Scholar
• Bannister S. J., Chang Y., Sternson L. A., Repta A. J. Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlor-idiammineplatinum (II). Clinical Chemistry 1978; 24: 877–880
   PubMed Web of Science ®Google Scholar
• Barlogie B., Corry P. M., Dre Winko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C. Cancer Research 1980; 40: 1165–1168
   PubMed Web of Science ®Google Scholar
• Boxenbaum G., Rigelman S., Elashoff R. M. Statistical estimation in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1974; 2: 123–148
   PubMedGoogle Scholar
• Bull J. M. C. An update on the anticancer effects of a combination of chemotherapy and hyuperthermia. Cancer Research 1984; 44: 4853–4856, Suppl.
   PubMed Web of Science ®Google Scholar
• Douple E. B., Strohbehn J. W., De Sieyes D. C., Alborough D. P., Trembly B. S. Therapeutic potentiation of cis-dichlorociammine microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph 1982; 61: 259–262
   Google Scholar
• Earhart R. H. Some quantitative data on cis-dichlorodiammineplatinum (II) species in solution. Cancer Treatment Reports 1979; 63: 231–233
   PubMedGoogle Scholar
• Earhart R. H., Martin P. A., Tutsch K. D., Erturk E., Wheeler R. H., Bull F. E. Improvement in the therapeutic index of cisplatin (NCS 119875) by pharmacologically induced chloruresis in the rat. Cancer Research 1983; 43: 1187–1194
   PubMed Web of Science ®Google Scholar
• Farris F. E., King F. G., Dedrick R. L., Litterst C. I. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat. Journal of Pharmacokinetics and Biopharmaceutics 1985; 13: 13–39
   PubMedGoogle Scholar
• Fisher G. A., Hahn G. M. Enhancement of cis-platinum (II) diamminedichloro cytotoxicity by hyperthermia. National Cancer Institute Monograph 1982; 61: 255–257
   Google Scholar
• Gerard H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diammine-tlichloroplatinum (II) and whole-body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
   PubMedGoogle Scholar
• Gibaldi M., Perrier D. Pharmacokinetics, 2nd edn. Marcel Dekker, New York 1982
   Google Scholar
• Herman T. S., Zukoski C. F., Anderson R. M., Hutter J. J., Blitt C. D., Malone J. M., Larson D. F., Dean J. C., Roth H. B. Whole-body hyperthermia and chemotherapy for treatment of patients with advanced refractory malignancies. Cancer Treatment Reports 1982; 66: 259–265
   PubMedGoogle Scholar
• Hull D. A., Muhammad N., Lanese J. G., Reich S. D., Finkelstein T. T., Fandrich S. Determination of platinum in serum and ultrafiltrate by flameless atomic absorption spectrophotometry. Journal of Pharmaceutical Sciences 1981; 70: 500–502
   PubMedGoogle Scholar
• Jacobs C., Kalman S. M., Tretton M., Weiner M. W. Renal handling of cis diamminedichloroplatinum (II). Cancer Treatment Reports 1980; 64: 1223–1226
   PubMedGoogle Scholar
• Leroy A. F. Interactions of platinum metals and their complexes in biological systems. Environmental Health perspectives 1975; 10: 73–84
   PubMedGoogle Scholar
• Leroy A. F., Lutz R. J., Dedrick R. L., Litterst C. L., Guarino A. M. Pharmacokinetic study of cis-dichlorodiammineplatinum (II) (DDP) in the beagle dog: Thermodynamic and kinetic behavior of DDP in a biologic milieu. Cancer Treatment Reports 1979; 63: 59–71
   PubMedGoogle Scholar
• Litterst C. L., Gram T. E., Dedrick R. L., Leroy A. F., Guarino A. M. Distribution and disposition of platinum following intravenous administration of cis diamminedichloroplatinum (II) (NCS 119875) to dogs. Cancer Research 1976; 36: 2340–2344
   PubMed Web of Science ®Google Scholar
• Litterst C. L., Leroy A. F., Guarino A. M. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum (II) to animals. Cancer Treatment Reports 1979; 63: 1485–1492
   PubMedGoogle Scholar
• Low D. F., Repta A. J. Cisplatin: chemistry, distribution, and biotransformation. Biopharmaceutics and Drug Disposition 1981; 1: 1–16
   Google Scholar
• Long D. F., Repta A. J., Sternson A. J. The reactivity of cisplatin in plasma. Implications for sample handling in pharmacokinetic stuidies. International Journal of Pharmaceutics 1980; 6: 167–173
   Web of Science ®Google Scholar
• Matsumoto K., Solin T., Fuwa K. Elimination of nitrate interference in the determination of platinum in some animal tissues using furnace atomic absorption spectrometry. Spectrochemica Acta 1984; 39B: 481–483
   Google Scholar
• Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-dichlorodiamminc platinum (II). Cancer Research 1980; 40: 1136–1139
   PubMed Web of Science ®Google Scholar
• Rilfy C. M., Sternson L. A., Repta A. J. Assessment of cisplatin reactivity with peptides and proteins using reverse phase high pressure liquid chromatography and flameless atomic absorption spectroscopy. A nnals of Biochemistry 1982; 124: 167–179
   PubMedGoogle Scholar
• Riviere J. E. The value and limitations of pharmacokinetics in predicting dose regimens. Effects of systemic disease. Symposium on the Determination of Doses of Veterinary Pharmaceuticals, T. D. Powers, T. E. Powers. Ohio State University Press, Columbus, Ohio 1984; 99–118
   Google Scholar
• Robins H. I., Dennis W. H., Neville A. J., Schecterle L. M., Martin P. A., Guossman J., Davis T. E., Neville S. R., Gillis W. K., Ruby B. F. A nontoxic system for 41.8°C whole body hyperthermia: Results of a phase I study using a radiant heat device. Cancer Research 1985; 45: 3937–3948
   PubMed Web of Science ®Google Scholar
• Rohins H. I., Grossman J., Davis T. E., Aubichon J. P., Dennis W. Preclinicai trial of a radiant heat device for whole body hyperthermia using a porcine model. Cancer Research 1983; 43: 2018–2022
   PubMedGoogle Scholar
• Safirstein R., Miller P., Guttenplan J. B. Uptake and metabolism of cisplatin by rat kidney. Kidney International 1984; 24: 753–758
   Google Scholar
• SAS. SAS Users' Guide: Statistics 1982, 1982. SAS Institute., Inc., Cary, NC 1982; 15–37
   Google Scholar
• Sedman A. J., Wagner J. G. CSTRIP, a Fortran IV computer program for obtitining initial polyexponential parameter estimates. Journal of Pharmaceutical Science 1976; 65: 1006–1010
   PubMed Web of Science ®Google Scholar
• Tucker M. A., Colvin C. B., Martin D. S. Substitution reactions of trichloro ammineplatinate (II) and the trans effect. Inorganic Chemistry 1964; 3: 1373–1382
   Google Scholar